activate
activation
activity
adenocarcinoma
adjuv
administr
alk
ALK
alteration
amplif
amplification
ampullari
analysis
associate
bile
blood
braf
BRAF
breast
cancer
carcinoma
case
cell
cervic
chemotherapi
cholangiocarcinoma
chromosom
clinical
colon
colorect
compare
complic
correlate
demonstrate
depress
detect
development
diabet
diagnosi
diseas
dna
drug
duct
ductal
effect
egfr
EGFR
emphysema
epidemiolog
exon
express
expression
factor
failur
find
fusion
gene
genet
genetic
group
growth
heart
HER2
high
human
hypertens
identify
imag
include
increase
induce
inhibitor
investigate
kinase
kras
KRAS
level
line
liposarcoma
loss
lung
mechanism
melanoma
meningioma
met
metabol
model
molecular
mortal
mouse
mutant
mutat
mutation
negative
neoadjuv
neoplasm
nf2
node
nsclc
NSCLC
observe
oncogene
overexpression
p53
pancreat
pancreatic
patholog
pathway
patient
pcr
PIK3CA
positive
potential
primari
primary
progression
proliferation
prostat
prostate
protein
pten
PTEN
pulmonari
radiat
radiotherapi
receptor
resect
resistance
response
result
risk
role
sample
show
signaling
significant
skin
small
specific
stage
status
study
suggest
surgeri
survival
syndrom 
target
therapeutic
therapi
therapy
tissue
treatment
trial
tumor
tumour
type
tyrosine
V600E
women
